Cargando…

Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration

PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Segelov, Eva, Chan, David, Lawrence, Ben, Pavlakis, Nick, Kennecke, Hagen F., Jackson, Christopher, Law, Calvin, Singh, Simron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560462/
https://www.ncbi.nlm.nih.gov/pubmed/28831446
http://dx.doi.org/10.1200/JGO.2016.006916
_version_ 1783257665687781376
author Segelov, Eva
Chan, David
Lawrence, Ben
Pavlakis, Nick
Kennecke, Hagen F.
Jackson, Christopher
Law, Calvin
Singh, Simron
author_facet Segelov, Eva
Chan, David
Lawrence, Ben
Pavlakis, Nick
Kennecke, Hagen F.
Jackson, Christopher
Law, Calvin
Singh, Simron
author_sort Segelov, Eva
collection PubMed
description PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modified Delphi process was undertaken involving patients, clinicians, and researchers to identify gaps in NETs research to produce a comprehensive and defensible research action plan. METHODS: A three-round modified Delphi process was undertaken with larger representation than usual for medical consensus processes. Patient/advocate and health care provider/researcher expert panels undertook Round 1, which canvassed 17 research priorities and 42 potential topics; in Round 2, these priorities were ranked. Round 3 comprised a face-to-face meeting to generate final consensus rankings and formulate the research action plan. RESULTS: The Delphi groups consisted of 203 participants in Round 1 (64% health care providers/researchers, 36% patient/advocates; 52% Canadian, 32% Australian, and 17% New Zealander), of whom 132 participated in Round 2. The top eight priorities were biomarker development; peptide receptor radionuclide therapy optimization; trials of new agents in advanced NETs; functional imaging; sequencing therapies for metastatic NETs, including development of validated surrogate end points for studies; pathologic classification; early diagnosis; interventional therapeutics; and curative surgery. Two major areas were ranked significantly higher by patients/advocates: early diagnosis and curative surgery. Six CommNETS working parties were established. CONCLUSION: This modified Delphi process resulted in a well-founded set of research priorities for the newly formed CommNETS collaboration by involving a large, diverse group of stakeholders. This approach to setting a research agenda for a new collaborative group should be adopted to ensure that research plans reflect unmet needs and priorities in the field.
format Online
Article
Text
id pubmed-5560462
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher American Society of Clinical Oncology
record_format MEDLINE/PubMed
spelling pubmed-55604622017-08-22 Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration Segelov, Eva Chan, David Lawrence, Ben Pavlakis, Nick Kennecke, Hagen F. Jackson, Christopher Law, Calvin Singh, Simron J Glob Oncol ORIGINAL REPORTS PURPOSE: Neuroendocrine tumors (NETs) are a diverse group of malignancies that pose challenges common to all rare tumors. The Commonwealth Neuroendocrine Tumor Collaboration (CommNETS) was established in 2015 to enhance outcomes for patients with NETs in Canada, Australia, and New Zealand. A modified Delphi process was undertaken involving patients, clinicians, and researchers to identify gaps in NETs research to produce a comprehensive and defensible research action plan. METHODS: A three-round modified Delphi process was undertaken with larger representation than usual for medical consensus processes. Patient/advocate and health care provider/researcher expert panels undertook Round 1, which canvassed 17 research priorities and 42 potential topics; in Round 2, these priorities were ranked. Round 3 comprised a face-to-face meeting to generate final consensus rankings and formulate the research action plan. RESULTS: The Delphi groups consisted of 203 participants in Round 1 (64% health care providers/researchers, 36% patient/advocates; 52% Canadian, 32% Australian, and 17% New Zealander), of whom 132 participated in Round 2. The top eight priorities were biomarker development; peptide receptor radionuclide therapy optimization; trials of new agents in advanced NETs; functional imaging; sequencing therapies for metastatic NETs, including development of validated surrogate end points for studies; pathologic classification; early diagnosis; interventional therapeutics; and curative surgery. Two major areas were ranked significantly higher by patients/advocates: early diagnosis and curative surgery. Six CommNETS working parties were established. CONCLUSION: This modified Delphi process resulted in a well-founded set of research priorities for the newly formed CommNETS collaboration by involving a large, diverse group of stakeholders. This approach to setting a research agenda for a new collaborative group should be adopted to ensure that research plans reflect unmet needs and priorities in the field. American Society of Clinical Oncology 2016-10-12 /pmc/articles/PMC5560462/ /pubmed/28831446 http://dx.doi.org/10.1200/JGO.2016.006916 Text en © 2016 by American Society of Clinical Oncology http://creativecommons.org/licenses/by-nc-nd/4.0/ Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle ORIGINAL REPORTS
Segelov, Eva
Chan, David
Lawrence, Ben
Pavlakis, Nick
Kennecke, Hagen F.
Jackson, Christopher
Law, Calvin
Singh, Simron
Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title_full Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title_fullStr Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title_full_unstemmed Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title_short Identifying and Prioritizing Gaps in Neuroendocrine Tumor Research: A Modified Delphi Process With Patients and Health Care Providers to Set the Research Action Plan for the Newly Formed Commonwealth Neuroendocrine Tumor Collaboration
title_sort identifying and prioritizing gaps in neuroendocrine tumor research: a modified delphi process with patients and health care providers to set the research action plan for the newly formed commonwealth neuroendocrine tumor collaboration
topic ORIGINAL REPORTS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5560462/
https://www.ncbi.nlm.nih.gov/pubmed/28831446
http://dx.doi.org/10.1200/JGO.2016.006916
work_keys_str_mv AT segeloveva identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT chandavid identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT lawrenceben identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT pavlakisnick identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT kenneckehagenf identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT jacksonchristopher identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT lawcalvin identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration
AT singhsimron identifyingandprioritizinggapsinneuroendocrinetumorresearchamodifieddelphiprocesswithpatientsandhealthcareproviderstosettheresearchactionplanforthenewlyformedcommonwealthneuroendocrinetumorcollaboration